Dual-Drug Conjugated Glyco-Nanoassemblies for Tumor-Triggered Targeting and Synergistic Cancer Therapy

被引:8
作者
Katmerlikaya, Tugba Gencoglu [1 ]
Dag, Aydan [5 ]
Ozgen, Pinar Sinem Omurtag [2 ,3 ]
Ersen, Busra Cetin [4 ]
机构
[1] Bezmialem Vakif Univ, Inst Hlth Sci, Dept Biotechnol, TR-34093 Istanbul, Turkey
[2] Istanbul Medipol Univ, Sch Pharm, Dept Analyt Chem, TR-34810 Istanbul, Turkey
[3] Marmara Univ, Fac Pharm, Dept Basic Pharm Sci, TR-34854 Istanbul, Turkey
[4] Ankara Haci Bayram Veli Univ, Inst Grad Studies, Dept Chem, TR-06900 Ankara, Turkey
[5] Bezmialem Vakif Univ, Fac Pharm & Pharmaceut Applicat & Res Ctr, Dept Pharmaceut Chem, TR-34093 Istanbul, Turkey
关键词
glyco-nanoassemblies; gemcitabine; cisPt; cellular uptake; synergistic chemotherapy; GEMCITABINE; DELIVERY;
D O I
10.1021/acsabm.2c00749
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Drug-conjugated nanoassemblies potentiate the efficiency of anticancer drugs through the advantages of high drug-loading capacity and passive/active targeting ability in cancer therapy. This study describes the synthesis of gemcitabine (Gem) and cisplatin (cisPt) dual-drug-functionalized glyco-nanoassemblies (GNs) for anticancer drug delivery systems. It also investigates the pH-triggered drug delivery of the conventional anticancer drug cisPt. A Gem-functionalized well-defined glycoblock copolymer backbone (P(iprFruMA-b-MAc)-Gem), which consists of fructose and methacrylic acid segments, was synthesized via a reversible addition-fragmentation chain transfer (RAFT) polymerization method. Following the hydrolysis of the protecting groups on the backbone copolymer, cisPt functionalization of P(FruMA-b-MAc)-Gem in aqueous media was carried out during the transformation of glycoblock polymers into self-assembled spherical glyco-nanoassemblies (GN3). Monodrug-functionalized glyco-nanoassemblies were also prepared either with Gem (GN1) or cisPt (GN2) to compare the synergetic effect of dual-drug conjugated glyco-nanoassemblies (GN3). The sizes of glyco-nanoassemblies GN1, GN2, and GN3 were found as 5.76 +/- 0.64, 59.80 +/- 0.13, and 53.80 +/- 3.90 nm and dispersity (D) values as 0.476, 0.292, and 0.311 by dynamic light scattering (DLS) measurement, respectively. The in vitro studies revealed that the drug-free glyco-nanoassemblies are biocompatible at concentrations higher than 296 mu g/mL. The drug-conjugated glyco-nanoassemblies (GN1 and GN2) exhibited in vitro cytotoxicity against human breast cancer cell lines of MDA-MB-231 comparable to free Gem and cisPt, illustrating an efficient drug release into the tumor environment. Additionally, GNs exhibited higher selectivity and preferential cellular internalization in MDA-MB-231 when compared to healthy cell lines of CCD-1079Sk. These dual-drug conjugated GNs can effectively enhance the killing of cancer cells and increase synergistic chemotherapy.
引用
收藏
页码:5356 / 5364
页数:9
相关论文
共 50 条
  • [1] Self-Assembled Nanoparticles for Tumor-Triggered Targeting Dual-Mode NIRF/MR Imaging and Photodynamic Therapy Applications
    Yang, Lun
    Tang, Jian
    Yin, Hui
    Yang, Jie
    Xu, Bin
    Liu, Yunkun
    Hu, Zhi
    Yu, Bentong
    Xia, Fangfang
    Zou, Guowen
    ACS BIOMATERIALS SCIENCE & ENGINEERING, 2022, 8 (02) : 880 - 892
  • [2] Dual-pH Sensitive Charge-Reversal Polypeptide Micelles for Tumor-Triggered Targeting Uptake and Nuclear Drug Delivery
    Han, Shi-Song
    Li, Ze-Yong
    Zhu, Jing-Yi
    Han, Kai
    Zeng, Zheng-Yang
    Hong, Wei
    Li, Wen-Xin
    Jia, Hui-Zhen
    Liu, Yun
    Zhuo, Ren-Xi
    Zhang, Xian-Zheng
    SMALL, 2015, 11 (21) : 2543 - 2554
  • [3] Dual-triggered drug-release vehicles for synergistic cancer therapy
    Tu, Ting-Yu
    Yang, Shu-Jyuan
    Tsai, Ming-Hsien
    Wang, Chung-Hao
    Lee, Shin-Yu
    Young, Tai-Horng
    Shieh, Ming-Jium
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2019, 173 : 788 - 797
  • [4] Encapsulation of Poorly Soluble Drugs in Polymer-Drug Conjugates: Effect of Dual-Drug Nanoformulations on Cancer Therapy
    Senanayake, Thulani H.
    Lu, Yaman
    Bohling, Anna
    Raja, Srikumar
    Band, Hamid
    Vinogradov, Serguei V.
    PHARMACEUTICAL RESEARCH, 2014, 31 (06) : 1605 - 1615
  • [5] Synergistic Targeting of Cancer and Associated Angiogenesis Using Triple-Targeted Dual-Drug Silica Nanoformulations for Theragnostics
    Veeranarayanan, Srivani
    Poulose, Aby Cheruvathoor
    Mohamed, M. Sheikh
    Varghese, Saino Hanna
    Nagaoka, Yutaka
    Yoshida, Yasuhiko
    Maekawa, Toru
    Kumar, D. Sakthi
    SMALL, 2012, 8 (22) : 3476 - 3489
  • [6] Dual-drug loaded micelle for combinatorial therapy targeting HIF and mTOR signaling pathways for ovarian cancer treatment
    Doddapaneni, Bhuvana S.
    AL-Fatease, Adel M.
    Rao, Deepa A.
    Alani, Adam W. G.
    JOURNAL OF CONTROLLED RELEASE, 2019, 307 : 272 - 281
  • [7] Facile construction of dual-drug loaded nanoparticles for improvement synergistic chemotherapy in prostate cancer
    Ma, Zhiqiang
    Ji, Tuo
    Ji, Guanghou
    Niu, Qingqing
    Han, Weiwei
    INTERNATIONAL JOURNAL OF POLYMERIC MATERIALS AND POLYMERIC BIOMATERIALS, 2023, 72 (11) : 856 - 866
  • [8] Dual-Drug Containing Core-Shell Nanoparticles for Lung Cancer Therapy
    Menon, Jyothi U.
    Kuriakose, Aneetta
    Iyer, Roshni
    Hernandez, Elizabeth
    Gandee, Leah
    Zhang, Shanrong
    Takahashi, Masaya
    Zhang, Zhang
    Saha, Debabrata
    Nguyen, Kytai T.
    SCIENTIFIC REPORTS, 2017, 7
  • [9] Tumor-Triggered Controlled Drug Release from Electrospun Fibers Using Inorganic Caps for Inhibiting Cancer Relapse
    Zhao, Xin
    Yuan, Ziming
    Yildirimer, Lara
    Zhao, Jingwen
    Lin, Zhi Yuan
    Cao, Zhi
    Pan, Guoqing
    Cui, Wenguo
    SMALL, 2015, 11 (34) : 4284 - 4291
  • [10] Dual-drug loaded phase-changing nanodroplets for image-guided tumor therapy
    Spatarelu, Catalina-Paula
    Jandhyala, Sidhartha
    Luke, Geoffrey P.
    COLLOIDAL NANOPARTICLES FOR BIOMEDICAL APPLICATIONS XV, 2020, 11255